Authors:
Buyse, M
Thirion, P
Carlson, RW
Burzykowski, T
Molenberghs, G
Piedbois, P
Citation: M. Buyse et al., Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer, J NAT CANC, 93(5), 2001, pp. 399-400
Authors:
Laudanski, J
Niklinska, W
Burzykowski, T
Chyczewski, L
Niklinski, J
Citation: J. Laudanski et al., Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer, EUR RESP J, 17(4), 2001, pp. 660-666
Citation: T. Burzykowski et G. Molenberghs, Validation of surrogate end points in multiple randomized clinical trials with failure time end points, J ROY STA C, 50, 2001, pp. 405-422
Authors:
Niklinska, W
Burzykowski, T
Chyczewski, L
Rusin, MR
Furman, M
Laudanski, J
Chyczewska, E
Sulik, M
Niklinski, J
Citation: W. Niklinska et al., p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland, EUR J CAN P, 9(2), 2000, pp. 81-87
Authors:
Buyse, M
Thirion, P
Carlson, RW
Burzykowski, T
Molenberghs, G
Piedbois, P
Citation: M. Buyse et al., Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis, LANCET, 356(9227), 2000, pp. 373-378
Citation: M. Buyse et al., Criteria for the validation of surrogate endpoints in randomized experiments (vol 54, pg 1014, 1998), BIOMETRICS, 56(1), 2000, pp. 324-325
Authors:
Ceremuzynski, L
Budaj, A
Czepiel, A
Burzykowski, T
Achremczyk, P
Smielak-Korombel, W
Maciejewicz, J
Dziubinska, J
Nartowicz, E
Kawka-Urbanek, T
Piotrowski, W
Hanzlik, J
Cieslinski, A
Kawecka-Jaszcz, K
Gessek, J
Wrabec, K
Citation: L. Ceremuzynski et al., Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: Results of a randomized multicenter Pol-GIK trial, CARDIO DRUG, 13(3), 1999, pp. 191-200
Authors:
Niklinski, J
Burzykowski, T
Niklinska, W
Laudanski, J
Chyczewski, L
Rapellino, M
Furman, M
Citation: J. Niklinski et al., Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer, EUR RESP J, 12(6), 1998, pp. 1424-1428
Authors:
Laudanski, J
Burzykowski, T
Niklinska, W
Chyczewski, L
Furman, M
Niklinski, J
Citation: J. Laudanski et al., Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer, LUNG CANC, 22(3), 1998, pp. 191-200